Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
2 competitors in Attention Deficit/Hyperactivity Disorder
View Full LandscapeTarget Indication
Attention Deficit/Hyperactivity Disorder
Clinical Trial
NCT05428033Last updated: 12/17/2025
No patent data available. Pre-approval drugs may not have Orange Book listings.
Attention Deficit Hyperactivity Disorder (ADHD)
Phenylketonuria (PKU)
Agitation Associated With
Hyperlipidemia
Attention-Deficit/Hyperactivity Disorder